EDAP TMS reported EUR7.91M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
AngioDynamics USD 37.29M 786K Sep/2025
Boston Scientific USD 1.83B 8M Mar/2026
EDAP TMS EUR 7.91M 1.31M Sep/2025
Henry Schein USD 2.3B 145M Mar/2026
Medtronic USD 3.61B 83M Dec/2025
Veracyte USD 38.49M 794K Mar/2026